Title of article :
Early Safety and Efficacy of Percutaneous Left Atrial Appendage Suture Ligation: Results From the U.S. Transcatheter LAA Ligation Consortium
Author/Authors :
Price، نويسنده , , Matthew J. and Gibson، نويسنده , , Douglas N. and Yakubov، نويسنده , , Steven J. and Schultz، نويسنده , , Jason C. and Di Biase، نويسنده , , Luigi and Natale، نويسنده , , Andrea and Burkhardt، نويسنده , , J. David and Pershad، نويسنده , , Ashish and Byrne، نويسنده , , Timothy J. and Gidney، نويسنده , , Brett and Aragon، نويسنده , , Joseph R. and Goldstein، نويسنده , , Jeffrey and Moulton، نويسنده , , Kriegh and Patel، نويسنده , , Taral and Knight، نويسنده , , Bradley and Lin، نويسنده , , Albert C. and Valderrلbano، نويسنده , , Miguel، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2014
Pages :
8
From page :
565
To page :
572
Abstract :
AbstractBackground atheter left atrial appendage (LAA) ligation may represent an alternative to oral anticoagulation for stroke prevention in atrial fibrillation. ives tudy sought to assess the early safety and efficacy of transcatheter ligation of the LAA for stroke prevention in atrial fibrillation. s as a retrospective, multicenter study of consecutive patients undergoing LAA ligation with the Lariat device at 8 U.S. sites. The primary endpoint was procedural success, defined as device success (suture deployment and <5 mm leak by post-procedure transesophageal echocardiography), and no major complication at discharge (death, myocardial infarction, stroke, Bleeding Academic Research Consortium bleeding type 3 or greater, or cardiac surgery). Post-discharge management was per operator discretion. s l of 154 patients were enrolled. Median CHADS2 score (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism [doubled]) was 3 (interquartile range: 2 to 4). Device success was 94%, and procedural success was 86%. A major complication occurred in 15 patients (9.7%). There were 14 major bleeds (9.1%), driven by the need for transfusion (4.5%). Significant pericardial effusion occurred in 16 patients (10.4%). Follow-up was available in 134 patients at a median of 112 days (interquartile range: 50 to 270 days): Death, myocardial infarction, or stroke occurred in 4 patients (2.9%). Among 63 patients with acute closure and transesophageal echocardiography follow-up, there were 3 thrombi (4.8%) and 13 (20%) with residual leak. sions s initial multicenter experience of LAA ligation with the Lariat device, the rate of acute closure was high, but procedural success was limited by bleeding. A prospective randomized trial is required to adequately define clinical efficacy, optimal post-procedure medical therapy, and the effect of operator experience on procedural safety.
Keywords :
Stroke , left atrial appendage , atrial fibrillation , Lariat
Journal title :
JACC (Journal of the American College of Cardiology)
Serial Year :
2014
Journal title :
JACC (Journal of the American College of Cardiology)
Record number :
1759058
Link To Document :
بازگشت